FDA FDA Public Meeting on Training Health Care Providers on Pain Management and… Thomas Sullivan May 23, 2017 0 In 2012, FDA instituted a risk evaluation and mitigation strategy (REMS) for extended-release and long-acting (ER/LA) opioids that…
